Friday 6 November 2026
Export WRBY’s income statement to Excel — free account
Warby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
26.28
0.20
+0.77%
Follow WRBY
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 6 |
+8 more TTM periods Free account |
| 1.93% | 2.06% | 0.37% | 0.46% | ||
| 1.00% | 1.05% | 0.19% | 0.23% | ||
ROIC |
0.83% | 0.98% | (4.38%) | (4.10%) | |
Return on Tangible Assets |
1.80% | 1.89% | 0.34% | 0.42% | |
Average Days of Receivables |
0.83 | 0.83 | 0.72 | 1.38 | |
Free Cash Flow per Share |
0.17 | 0.18 | 0.32 | 0.36 | |
Free Cash Flow |
21.29 | 21.75 | 38.90 | 43.74 | |
Capital Expenditures |
(80.82) | (73.61) | (67.03) | (67.05) | |
| Other line items | |||||
Cash ROIC |
3.08% | 3.18% | 5.86% | 6.69% | |
Accounts Receivable Turnover |
570.79 | 566.39 | 550.75 | 333.23 | |
Accounts Payable Turnover |
21.36 | 12.28 | 13.02 | 14.46 | |
Inventory Turnover |
9.21 | 9.68 | 8.73 | 8.29 | |
Average Days of Payables |
24.79 | 36.46 | 32.73 | 29.08 | |
Days of Inventory on Hand |
39.94 | 37.20 | 40.86 | 40.48 | |
Tax Rate |
(0.28) | (0.22) | (0.36) | (0.46) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
54.58% | 54.51% | 54.10% | 54.58% | |
Share Based Compensation of Revenue |
3.86% | 3.80% | 3.77% | 3.96% | |
Interest Coverage |
(0.18) | (0.19) | 0.74 | 0.64 | |
Operating CF/Net income |
13.67 | 12.32 | 78.71 | 67.51 | |
Depreciation/Fixed assets |
0.00 | 0.28 | 0.29 | 0.29 | |
Capex/Depreciation |
0.00 | (1.28) | (1.21) | (1.25) | |
Revenue per Share |
7.49 | 7.36 | 7.21 | 7.11 | |
Operating CF per Share |
0.82 | 0.77 | 0.86 | 0.90 | |
Capex per Share |
(0.65) | (0.59) | (0.54) | (0.55) | |
Capex to Sales |
0.09 | 0.08 | 0.08 | 0.08 |
Columns are period end dates · fundamentals updated 5 Nov 2026